LITTLETON, Mass.
Mevion Medical Systems has signed an agreement with Tianjin Port Free Trade Zone Administrative Committee and Tianyi Holdings to develop a proton therapy center in the rapidly growing research and development hub, the Tianjin Airport Economic Area. The agreement was signed at the China International Import Expo.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191112005325/en/
Joint signing ceremony for the agreement: (from left to right) Fuju Zhang, Vice President, China at Mevion Medical Systems, Tiancheng You, Director of Tianjin Port Free Trade Zone Administrative Committee and Peng Zhou, Vice President of Tianyi Holdings Ltd. Co. signed the agreement on behalf of the three parties. (Photo: Business Wire)
Under the agreement, the three parties will partner to develop a state-of-the-art proton therapy center to bring advanced healthcare services to Tianjin and its surrounding areas. In addition to clinical services, the Tianjin center will also pursue research activities to advance proton therapy.
The Tianjin Airport Economic Area was founded in 2015 to be a free trade hub supporting research and development of next-generation life sciences, aerospace technologies, and high-tech manufacturing.
About Mevion Medical Systems
Mevion Medical Systems, Inc. is the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients. Mevion is based in Littleton, Massachusetts, with a presence in Europe and China. For more information, please visit www.mevion.com
Follow us on Twitter: @MevionMedical
Connect with us on LinkedIn: Mevion Medical Systems
Like Us on Facebook: MevionMedical
View source version on businesswire.com: https://www.businesswire.com/news/home/20191112005325/en/
CONTACT
Melanie Benton
Mevion Medical Systems
Mbenton@mevion.com 1-978-540-1551
